Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 江苏辉丰农化股份有限公司是一家生产化学农药产品的公司.公司主要产品为咪鲜胺原药、辛酰溴苯腈原药、二氰蒽醌原药、吡氟酰草胺原药、氟环唑原药及其他农药制剂产品,公司已成为全球最大的咪鲜胺原药生产企业之一,国内最大的辛酰溴苯腈原药、氟环唑原药生产企业之一.全球第一大农药公司拜耳公司、第三大农药公司巴斯夫公司、第七大农药公司马克西姆公司、第八大农药公司纽发姆公司均已成为公司稳定的客户.公司拥有10项发明专利,另有22项发明专利处于审查之中.公司于2008年被人力资源与社会保障部、中国石油和化学工业协会联合评为"全国石油和化学工业先进集体".公司以优质产品为依托,在国内已树立"辉丰"制造品牌、"UFA"服务品牌等良好品牌形象,"辉丰"品牌被认定为"江苏省著名商标","辉丰"牌咪鲜胺产品被认定为"江苏名牌产品","阳光雨露元素"、"青蛙博士"等标识亦已深入人心。
Main Business 生物农资、农资电商、石化仓储供应链及项目投资
Legal Representative 仲汉根
Top Executives
董事长：仲汉根
副董事长：裴柏平
董事：冷盼盼,杨进华,周京,裴柏平,张建国
独立董事：杨兆全,花荣军,李昌莲
Top 5 Shareholder
Shareholder name Nature Holding Date
仲汉根限售股+流通A股28.75%30/09/2024
张宏德流通A股3.33%30/09/2024
苏仕流通A股2.14%30/09/2024
江苏辉丰生物农业股份有限公司－第一期员工持股计划流通A股2.03%30/09/2024
余峰流通A股1.33%30/09/2024
Company Secretary 孙永良
Solicitors 江苏涤非律师事务所
Auditors 天健会计师事务所（特殊普通合伙）
Tel No 0515-85055999;0021-61257268;0515-85055568
Fax No 0515-83516755
Website www.hfagro.com
Email jshuifenggufen@163.com
Company Address
Register: 江苏省盐城市大丰区海洋经济开发区南区纬二路(王港闸南首)
Office: 江苏省盐城市大丰区海洋经济开发区南区纬二路(王港闸南首)
Listing Date 09/11/2010
Shares Capital
Shares Capital: 1,507,589,677
Total A Share: 1,507,589,677
Listed A Share: 1,181,386,559
Non-tradable A Share: 326,203,118
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.310
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 0.986
Market Capitalization(RMB) 2.753B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.